SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...
Saved in:
Main Authors: | T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
by: Masmudur M. Rahman, et al.
Published: (2021) -
Oncolytic Virotherapy
Published: (2016) -
SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
by: T. S. Nepomnyashchikh, et al.
Published: (2017) -
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
by: Xin Xie, et al.
Published: (2022) -
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
by: Gang Shi, et al.
Published: (2021)